1 - 25 of 29 results for author:"Evans J.F." in Literature citations
Results Customize
› Repeat search in UniProtKB (22)
| Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPD. Zhu J., Bandi V., Qiu S., Figueroa D.J., Evans J.F., Barnes N., Guntupalli K.K., Jeffery P.K. Chest 142:347-357(2012) · Mapped (3) |
| Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells. Evans J.F., Fernando A., Ragolia L. Mol. Cell. Endocrinol. 355:60-70(2012) · Mapped (2) |
| Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. Lorrain D.S., Bain G., Correa L.D., Chapman C., Broadhead A.R., Santini A.M., Prodanovich P.P., Darlington J.V., Stock N.S., Zunic J. et al. Eur. J. Pharmacol. 640:211-218(2010) · Mapped (1) |
| Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation. Lorrain D.S., Bain G., Correa L.D., Chapman C., Broadhead A.R., Santini A.M., Prodanovich P., Darlington J.V., Hutchinson J.H., King C. et al. J. Pharmacol. Exp. Ther. 331:1042-1050(2009) · Mapped (1) |
| Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis. Stearns B.A., Baccei C., Bain G., Broadhead A., Clark R.C., Coate H., Evans J.F., Fagan P., Hutchinson J.H., King C. et al. Bioorg. Med. Chem. Lett. 19:4647-4651(2009) · Mapped (1) |
| The nuclear membrane organization of leukotriene synthesis. Mandal A.K., Jones P.B., Bair A.M., Christmas P., Miller D., Yamin T.-T., Wisniewski D., Menke J., Evans J.F., Hyman B.T. et al. Proc. Natl. Acad. Sci. U.S.A. 105:20434-20439(2008) · UniProtKB (1) · Mapped (17) |
| Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors. Xu S., McKeever B.M., Wisniewski D., Miller D.K., Spencer R.H., Chu L., Ujjainwalla F., Yamin T.T., Evans J.F., Becker J.W. et al. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 63:1054-1057(2007) · Mapped (1) |
| Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein. Ferguson A.D., McKeever B.M., Xu S., Wisniewski D., Miller D.K., Yamin T.-T., Spencer R.H., Chu L., Ujjainwalla F., Cunningham B.R. et al. Science 317:510-512(2007) · UniProtKB (1) |
| A possible role for melanocortin peptides in longitudinal growth. Yeh J.K., Evans J.F., Niu Q.T., Aloia J.F. J. Endocrinol. 191:677-686(2006) · Mapped (4) |
| Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Uzonyi B., Lotzer K., Jahn S., Kramer C., Hildner M., Bretschneider E., Radke D., Beer M., Vollandt R., Evans J.F. et al. Proc. Natl. Acad. Sci. U.S.A. 103:6326-6331(2006) · Mapped (10) |
| Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Zhu J., Qiu Y.S., Figueroa D.J., Bandi V., Galczenski H., Hamada K., Guntupalli K.K., Evans J.F., Jeffery P.K. Am. J. Respir. Cell Mol. Biol. 33:531-540(2005) · Mapped (5) |
| The membrane organization of leukotriene synthesis. Mandal A.K., Skoch J., Bacskai B.J., Hyman B.T., Christmas P., Miller D., Yamin T.T., Xu S., Wisniewski D., Evans J.F. et al. Proc. Natl. Acad. Sci. U.S.A. 101:6587-6592(2004) · Mapped (3) |
| Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4. Yang G., Haczku A., Chen H., Martin V., Galczenski H., Tomer Y., Van Besien C.R., Evans J.F., Panettieri R.A., Funk C.D. et al. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L992-1001(2004) · Mapped (3) |
| A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. Thompson M.D., Storm van's Gravesande K., Galczenski H., Burnham W.M., Siminovitch K.A., Zamel N., Slutsky A., Drazen J.M., George S.R., Evans J.F. et al. Pharmacogenetics 13:641-649(2003) · Mapped (3) |
| Discovery and mapping of ten novel G protein-coupled receptor genes. Lee D.K., Nguyen T., Lynch K.R., Cheng R., Vanti W.B., Arkhitko O., Lewis T., Evans J.F., George S.R., O'Dowd B.F. Gene 275:83-91(2001) · UniProtKB (10) |
| Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G., Ash C., Hay K., Redston M., Kwong E., Hancock B., Mak T., Kargman S., Evans J.F., Gallinger S. Cancer Res. 61:6131-6136(2001) · Mapped (16) |
| Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Oshima M., Murai N., Kargman S., Arguello M., Luk P., Kwong E., Taketo M.M., Evans J.F. Cancer Res. 61:1733-1740(2001) · Mapped (14) |
| Identification of receptors for neuromedin U and its role in feeding. Howard A.D., Wang R., Pong S.-S., Mellin T.N., Strack A., Guan X.-M., Zeng Z., Williams D.L., Feighner S.D., Nunes C.N. et al. |
| Characterization of the human cysteinyl leukotriene 2 receptor. Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T., Im D.-S., Stocco R., Bellefeuille J.N., Abramovitz M., Cheng R. et al. J. Biol. Chem. 275:30531-30536(2000) · UniProtKB (1) |
| Synthesis of the nanomolar photoaffinity GABA(B) receptor ligand CGP 71872 reveals diversity in the tissue distribution of GABA(B) receptor forms. Belley M., Sullivan R., Reeves A., Evans J.F., O'Neill G.P., Ng G.Y.K. Bioorg. Med. Chem. 7:2697-2704(1999) · UniProtKB (1) |
| Characterization of the human cysteinyl leukotriene CysLT1 receptor. Lynch K.R., O'Neill G.P., Liu Q., Im D.-S., Sawyer N., Metters K.M., Coulombe N., Abramovitz M., Figueroa D.J., Zeng Z. et al. Nature 399:789-793(1999) · UniProtKB (1) |
| Cloning of a novel G-protein-coupled receptor GPR 51 resembling GABAB receptors expressed predominantly in nervous tissues and mapped proximal to the hereditary sensory neuropathy type 1 locus on chromosome 9. Ng G.Y.K., McDonald T., Bonnert T., Rigby M., Heavens R., Whiting P., Chateauneuf A., Coulombe N., Kargman S., Caskey T. et al. Genomics 56:288-295(1999) · UniProtKB (1) |
| Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. Ng G.Y.K., Clark J., Coulombe N., Ethier N., Hebert T.E., Sullivan R., Kargman S., Chateauneuf A., Tsukamoto N., McDonald T. et al. J. Biol. Chem. 274:7607-7610(1999) · UniProtKB (2) |
| Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Cell 87:803-809(1996) · Mapped (14) |
| 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. Woods J.W., Evans J.F., Ethier D., Scott S., Vickers P.J., Hearn L., Heibein J.A., Charleson S., Singer I.I. J. Exp. Med. 178:1935-1946(1993) · UniProtKB (2) |